Galectin Therapeutics (GALT) EBITDA (2009 - 2017)
Galectin Therapeutics (GALT) posted EBITDA of -$8.18 million for Q2 2021, compared with -$6.09 million a year earlier.
Powered by 
Analysis
Galectin Therapeutics (GALT) EBITDA (2009 - 2017) Analysis & Trends
For the trailing twelve months through Jun 30, 2021, EBITDA at Galectin Therapeutics was -$28.23 million; for FY2020, it was -$23.41 million.
- In prior years, Galectin Therapeutics' EBITDA was -$13.4 million in FY2019, -$13.6 million in FY2018, -$16.25 million in FY2017 and -$21.47 million in FY2016.
- The Q2 2021 figure stands as the lowest quarterly EBITDA in data going back to Q3 2010.
- According to Business Quant data, EBITDA for the three prior quarters was -$6.31 million (Q1 2021), -$7.82 million (Q4 2020) and -$5.92 million (Q3 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Galectin Therapeutics | 224.13 Mn | 167.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -2.37 Mn |
| Sep 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.51 Mn |
| Mar 31, 2017 | -4.95 Mn |
| Dec 31, 2016 | -4.60 Mn |
| Sep 30, 2016 | -4.54 Mn |
| Jun 30, 2016 | -5.53 Mn |
| Mar 31, 2016 | -6.81 Mn |
| Dec 31, 2015 | -4.68 Mn |
| Sep 30, 2015 | -5.90 Mn |
| Jun 30, 2015 | -4.66 Mn |
| Mar 31, 2015 | -4.84 Mn |
| Dec 31, 2014 | -3.73 Mn |
| Sep 30, 2014 | -3.47 Mn |
| Jun 30, 2014 | -3.37 Mn |
| Mar 31, 2014 | -4.84 Mn |
| Dec 31, 2013 | -2.80 Mn |
| Sep 30, 2013 | -3.54 Mn |
| Jun 30, 2013 | -2.54 Mn |
| Mar 31, 2013 | -3.21 Mn |
API Access
Galectin Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();